ScienceDex / Researcher record
Rajan, Arun
- Division of Basic Sciences - Nci (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Top 5% Funded
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2019 | $70,247 | 5 | #41,089 |
| 2021 | $1,010,133 | 6 | #9,091 |
| 2022 | $5,301,472 | 9 | #662 |
| 2023 | $4,670,283 | 9 | #840 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20195 records
- FY20216 records
- FY2022 · selected9 records
- FY20239 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Rajan, Arun as a PI. Multi-PI records show the full award amount for context.
- $3.7Maward amount
- 1ZIDBC011683-07ZIDContact PIMedical Oncology HIV-AIDS Clinical Research$646.2Kaward amount
- 1ZIABC011900-04ZIAContact PIPilot Study of Avelumab in Thymic Epithelial Tumors$298Kaward amount
- 1ZIABC012106-01ZIAContact PIA Phase II Trial of PT-112 in Subjects with Thymoma and Thymic Carcinoma$268.2Kaward amount
- 1ZIABC012001-03ZIAContact PIPhase II Trial of Bintrafusp Alfa in Subjects with Thymoma and Thymic Carcinoma$198.6Kaward amount
- 1ZIABC011907-04ZIAContact PIDurvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer$99.3Kaward amount
- 1ZIABC011905-04ZIAContact PIAnti-PD-L1-TGFb antibody (M7824) in advanced non-small cell lung cancer$99.3Kaward amount
- $19.9Kaward amount
- 1ZIABC011906-04ZIAContact PICV301 and Anti-PD-1 Therapy in Non-Small Cell Lung Cancer$9.9Kaward amount
Award organization
Organizations that administered FY2022 awards listing Rajan, Arun as a PI.
FY2022 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardDivision of Basic Sciences - Nci
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #9091
- 2022$2M Cumulative Funding
- 2022$5M Cumulative Funding
- 2022Entered Top 25% NationallyRanked #662
- 2022Entered Top 10% NationallyRanked #662
- 2022Entered Top 5% NationallyRanked #662
- 2023$10M Cumulative Funding